REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,366,436 | +258.4% | 53,988 | +356.1% | 0.20% | +288.5% |
| Q1 2023 | $381,302 | -43.0% | 11,838 | -67.3% | 0.05% | -45.3% |
| Q4 2022 | $669,175 | +187.2% | 36,250 | +360.8% | 0.10% | +131.7% |
| Q2 2021 | $233,000 | -64.6% | 7,866 | -70.0% | 0.04% | -51.2% |
| Q3 2020 | $659,000 | +137.9% | 26,199 | +130.6% | 0.08% | +133.3% |
| Q2 2020 | $277,000 | +136.8% | 11,360 | +43.5% | 0.04% | +125.0% |
| Q1 2020 | $117,000 | -22.0% | 7,918 | -14.1% | 0.02% | -36.0% |
| Q4 2019 | $150,000 | – | 9,213 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |